A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research

Cohn, David

5 - Scientific Plenary
A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research

Saturday, March 22, 2014: 9:14 AM

Ballroom B/C (Tampa Convention Center)

D. E. Cohn¹, J. C. Barnett², L. Wenzel³, B. J. Monk⁴, R. A. Burger⁵, E. Myers⁶ and L. J. Havrilesky⁶
¹The Ohio State University, Columbus, OH, ²San Antonio Military Medical Center, Ft. Sam Houston, TX, ³University of California, Irvine, Irvine, CA, ⁴Creighton University School of Medicine, St. Joseph’s Hospital and Medical Center, Phoenix,, AZ, ⁵University of Pennsylvania, Philadelphia, PA, ⁶Duke University Medical Center, Durham, NC

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

5 - Scientific Plenary
A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research

5 - Scientific Plenary A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research

5 - Scientific Plenary
A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research